559 related articles for article (PubMed ID: 34440392)
1.
Fyke W; Velinov M
Genes (Basel); 2021 Aug; 12(8):. PubMed ID: 34440392
[TBL] [Abstract][Full Text] [Related]
2. Screening for
Hnoonual A; Jankittunpaiboon C; Limprasert P
Biomed Res Int; 2021; 2021():4359308. PubMed ID: 34926684
[TBL] [Abstract][Full Text] [Related]
3. Incomplete silencing of full mutation alleles in males with fragile X syndrome is associated with autistic features.
Baker EK; Arpone M; Aliaga SM; Bretherton L; Kraan CM; Bui M; Slater HR; Ling L; Francis D; Hunter MF; Elliott J; Rogers C; Field M; Cohen J; Cornish K; Santa Maria L; Faundes V; Curotto B; Morales P; Trigo C; Salas I; Alliende AM; Amor DJ; Godler DE
Mol Autism; 2019; 10():21. PubMed ID: 31073396
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic characterization of the FMR1 gene and aberrant neurodevelopment in human induced pluripotent stem cell models of fragile X syndrome.
Sheridan SD; Theriault KM; Reis SA; Zhou F; Madison JM; Daheron L; Loring JF; Haggarty SJ
PLoS One; 2011; 6(10):e26203. PubMed ID: 22022567
[TBL] [Abstract][Full Text] [Related]
5. Unstable mutations in the FMR1 gene and the phenotypes.
Loesch D; Hagerman R
Adv Exp Med Biol; 2012; 769():78-114. PubMed ID: 23560306
[TBL] [Abstract][Full Text] [Related]
6. Double Genetic Hit: Fragile X Syndrome and Partial Deletion of Protein Patched Homolog 1 Antisense as Cause of Severe Autism Spectrum Disorder.
Saldarriaga W; Payán-Gómez C; González-Teshima LY; Rosa L; Tassone F; Hagerman RJ
J Dev Behav Pediatr; 2020 Dec; 41(9):724-728. PubMed ID: 32947579
[TBL] [Abstract][Full Text] [Related]
7. Tau reduction attenuates autism-like features in Fmr1 knockout mice.
Zhao S; Jiang X; Han L; Jiang Y; Wang Y; Meng J; Zhu X; Zhang X; Luo H; Zhang YW
Mol Autism; 2023 Nov; 14(1):42. PubMed ID: 37936174
[TBL] [Abstract][Full Text] [Related]
8. Proteome profiling of the prefrontal cortex of Fmr1 knockout mouse reveals enhancement of complement and coagulation cascades.
Gao MM; Shi H; Yan HJ; Long YS
J Proteomics; 2023 Mar; 274():104822. PubMed ID: 36646274
[TBL] [Abstract][Full Text] [Related]
9. Sex-specific modulation of early life vocalization and cognition by Fmr1 gene dosage in a mouse model of Fragile X Syndrome.
Giua G; Iezzi D; Caceres-Rodriguez A; Strauss B; Chavis P; Manzoni OJ
Biol Sex Differ; 2024 Feb; 15(1):18. PubMed ID: 38383408
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic variability to medication management: an update on fragile X syndrome.
Elhawary NA; AlJahdali IA; Abumansour IS; Azher ZA; Falemban AH; Madani WM; Alosaimi W; Alghamdi G; Sindi IA
Hum Genomics; 2023 Jul; 17(1):60. PubMed ID: 37420260
[TBL] [Abstract][Full Text] [Related]
11. Point mutation frequency in the FMR1 gene as revealed by fragile X syndrome screening.
Handt M; Epplen A; Hoffjan S; Mese K; Epplen JT; Dekomien G
Mol Cell Probes; 2014; 28(5-6):279-83. PubMed ID: 25171808
[TBL] [Abstract][Full Text] [Related]
12. Melatonin as a Novel Interventional Candidate for Fragile X Syndrome with Autism Spectrum Disorder in Humans.
Won J; Jin Y; Choi J; Park S; Lee TH; Lee SR; Chang KT; Hong Y
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28632163
[TBL] [Abstract][Full Text] [Related]
13. Intellectual functioning and behavioural features associated with mosaicism in fragile X syndrome.
Baker EK; Arpone M; Vera SA; Bretherton L; Ure A; Kraan CM; Bui M; Ling L; Francis D; Hunter MF; Elliott J; Rogers C; Field MJ; Cohen J; Maria LS; Faundes V; Curotto B; Morales P; Trigo C; Salas I; Alliende AM; Amor DJ; Godler DE
J Neurodev Disord; 2019 Dec; 11(1):41. PubMed ID: 31878865
[TBL] [Abstract][Full Text] [Related]
14. The feasibility and utility of hair follicle sampling to measure FMRP and FMR1 mRNA in children with or without fragile X syndrome: a pilot study.
Jalnapurkar I; Frazier JA; Roth M; Cochran DM; Foley A; Merk T; Venuti L; Ronco L; Raines S; Cadavid D
J Neurodev Disord; 2022 Dec; 14(1):57. PubMed ID: 36494616
[TBL] [Abstract][Full Text] [Related]
15. Adaptive, behavioral, and cognitive outcomes in individuals with fragile X syndrome with varying autism severity.
Aishworiya R; Tak YE; Ponzini MD; Biag HMB; Salcedo-Arellano MJ; Kim K; Tassone F; Schneider A; Thurman AJ; Abbeduto L; Hessl D; Randol JL; Bolduc FV; Lippe S; Hagerman P; Hagerman R
Int J Dev Neurosci; 2023 Dec; 83(8):715-727. PubMed ID: 37724826
[TBL] [Abstract][Full Text] [Related]
16. microRNAs and Fragile X Syndrome.
Lin SL
Adv Exp Med Biol; 2015; 888():107-21. PubMed ID: 26663181
[TBL] [Abstract][Full Text] [Related]
17. A Genotype-Phenotype Study of High-Resolution
Budimirovic DB; Schlageter A; Filipovic-Sadic S; Protic DD; Bram E; Mahone EM; Nicholson K; Culp K; Javanmardi K; Kemppainen J; Hadd A; Sharp K; Adayev T; LaFauci G; Dobkin C; Zhou L; Brown WT; Berry-Kravis E; Kaufmann WE; Latham GJ
Brain Sci; 2020 Sep; 10(10):. PubMed ID: 33008014
[TBL] [Abstract][Full Text] [Related]
18. Autism spectrum disorders and attention-deficit/hyperactivity disorder in boys with the fragile X premutation.
Farzin F; Perry H; Hessl D; Loesch D; Cohen J; Bacalman S; Gane L; Tassone F; Hagerman P; Hagerman R
J Dev Behav Pediatr; 2006 Apr; 27(2 Suppl):S137-44. PubMed ID: 16685180
[TBL] [Abstract][Full Text] [Related]
19. Cerebellar contribution to autism-relevant behaviors in fragile X syndrome models.
Gibson JM; Vazquez AH; Yamashiro K; Jakkamsetti V; Ren C; Lei K; Dentel B; Pascual JM; Tsai PT
Cell Rep; 2023 Dec; 42(12):113533. PubMed ID: 38048226
[TBL] [Abstract][Full Text] [Related]
20. Epigenetics of fragile X syndrome and fragile X-related disorders.
Kraan CM; Godler DE; Amor DJ
Dev Med Child Neurol; 2019 Feb; 61(2):121-127. PubMed ID: 30084485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
